🇺🇸
HANGZHOU, China and SHANGHAI and BOSTON, July 14, 2026 /PRNewswire/ — Lynk Pharmaceuticals Co., Ltd. (“Lynk Pharmaceuticals”), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that patient enrollment was completed on July 9…
Source: prnewswire
Country: United States